| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.23B | 23.24B | 21.91B | 18.66B | 12.70B | 16.27B |
| Gross Profit | 5.24B | 6.33B | 6.50B | 3.46B | 929.09M | 4.76B |
| EBITDA | 7.39B | 8.37B | 9.39B | 6.61B | -884.09M | 6.99B |
| Net Income | 3.30B | 4.04B | 3.35B | 1.46B | -4.99B | 2.38B |
Balance Sheet | ||||||
| Total Assets | 84.41B | 81.04B | 72.08B | 68.25B | 59.39B | 65.96B |
| Cash, Cash Equivalents and Short-Term Investments | 7.66B | 5.66B | 5.63B | 4.24B | 3.52B | 4.87B |
| Total Debt | 37.45B | 33.71B | 29.71B | 30.22B | 25.46B | 26.03B |
| Total Liabilities | 44.60B | 42.06B | 34.98B | 34.68B | 29.47B | 30.36B |
| Stockholders Equity | 36.70B | 35.87B | 35.16B | 31.57B | 28.59B | 34.62B |
Cash Flow | ||||||
| Free Cash Flow | 1.24B | 749.93M | 3.02B | -238.76M | 468.51M | 1.56B |
| Operating Cash Flow | 8.00B | 8.63B | 8.66B | 4.21B | 3.39B | 7.07B |
| Investing Cash Flow | -5.79B | -8.76B | -4.60B | -5.19B | -2.64B | -4.91B |
| Financing Cash Flow | 948.95M | -102.21M | -2.73B | 1.52B | -2.08B | -1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$256.44B | 6.39 | 13.13% | 12.48% | 30.56% | 108.49% | |
82 Outperform | HK$93.20B | 7.76 | 48.55% | 9.80% | 37.68% | 127.44% | |
74 Outperform | HK$136.81B | 5.59 | 9.13% | 4.76% | 4.90% | 6.33% | |
71 Outperform | HK$91.46B | 7.02 | 11.33% | 12.81% | 28.91% | 150.66% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | HK$14.88B | 26.23 | 2.51% | 2.88% | -4.94% | 22.86% | |
47 Neutral | HK$35.65B | 14.39 | 5.24% | 4.16% | 29.67% | 79.82% |